article thumbnail

Expert consortium comment on FDA report on risk of T-cell malignancy  

Drug Discovery World

ISCT, the global society of clinicians, researchers, regulators, technologists, and industry partners dedicated to the translation of cell and gene therapy (CGT) into safe and effective therapies to improve patients’ lives, aligns with the FDA in support of the need for thorough investigation and transparency.

article thumbnail

IN FOCUS: Solvias

Pharmaceutical Technology

The move is particularly timely given the significant growth expected in global sales of cell and gene therapies. The deal allows the company to provide proprietary technology and knowledge steeped in fast-evolving genomic techniques that support effective decision-making and R&D program design.